Articles related to ASTHMA

Allergy testing in asthma is most useful when results could change management, with clinical history guiding targeted sensitization testing and total IgE serving a limited role outside anti-IgE biologic assessment.

The GINA 2026 update introduces age-stratified primary care flowcharts for asthma exacerbation management, expands biologic guidance including depemokimab, and adds a formal red-flag list for fatal or near-fatal asthma risk in adults and adolescents.

A DNA methylation–based IgE score measured in infancy was associated with recurrent wheezing by age 3 across three pediatric cohorts.

The working group strongly recommended inhaled corticosteroids (ICS) and streamlined management of asthma by suggesting a combination of ICS and rapid-onset long-acting β-agonist as both reliever and controller agents and step-up therapy by increasing ICS and/or adding long-acting anticholinergic agents.

“Today’s approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.” – Iilun Murphy, MD, Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research

In pregnancy, asthma effects vary significantly: one-third of patients experience worsening symptoms, one-third improve, and one-third remain stable. Properly controlled asthma during pregnancy does not increase maternal or infant complications.